Development of Machine Learning Model to Predict the 5-Year Risk of Starting Biologic Agents in Patients with Inflammatory Bowel Disease (IBD): K-CDM Network Study
Details
The content you want is available to Zendy users.Already have an account? Click here. to sign in.